COVID-19 Variant Supplement - SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.
COVID-19 Variant Supplement - SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.
COVID-19 变异补充剂 - 通过基因筛选和重新利用针对重要病毒与宿主相互作用的药物发现 SARS-CoV2 治疗方法。
批准号：
443209
负责人：
Wilson Joyce A
金额：
$3.64万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-02-01 至 2022-02-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The worldwide pandemic of COVID19 caused by the virus SARS-CoV2 has caused over 270,000 human lives and worldwide economic collapse. While public health measures such as social distancing and shutdown of non-essential businesses have been effective at slo
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reverse genetic analysis of mechanisms underlying convergent evolution of SARS-CoV-2 variants of concern and accessory protein functions
-
批准号：484207
-
项目类别：Operating Grants
-
资助金额：$7.29万
-
财政年份：2023
-
负责人：Wilson Joyce A
-
依托单位：
Unraveling the Evolution of COVID-19: The Impact of Variant Mutations and ORF8 on Virus Replication and Pathogenesis to Enhance Pandemic Preparedness
-
批准号：494298
-
项目类别：Operating Grants
-
资助金额：$7.29万
-
财政年份：2023
-
负责人：Wilson Joyce A
-
依托单位：
SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions.
-
批准号：429488
-
项目类别：Operating Grants
-
资助金额：$32.73万
-
财政年份：2020
-
负责人：Wilson Joyce A
-
依托单位：
Fourth Canadian Symposium on Hepatitis C Virus
-
批准号：314916
-
项目类别：Miscellaneous Programs
-
资助金额：$0.73万
-
财政年份：2014
-
负责人：Wilson Joyce A
-
依托单位：
Mechanistic analysis and therapeutic targeting of miR-122 and HCV
-
批准号：291905
-
项目类别：Operating Grants
-
资助金额：$36.5万
-
财政年份：2013
-
负责人：Wilson Joyce A
-
依托单位：
海外基金
